Operator: Good day and welcome to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

March 6th, 2023 - News Transcripts

Were Hedge Funds Right About EyePoint Pharmaceuticals, Inc. (EYPT)?

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

July 30th, 2021 - Hedge Funds News

Where Do Hedge Funds Stand On EyePoint Pharmaceuticals, Inc. (EYPT)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

November 25th, 2020 - Hedge Funds News

Should You Buy EyePoint Pharmaceuticals, Inc. (EYPT)?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

May 27th, 2020 - Hedge Funds News

EyePoint Pharmaceuticals, Inc. (EYPT): Hedge Fund Sentiment Unchanged

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.

Keep Reading →

December 22nd, 2019 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On EyePoint Pharmaceuticals, Inc. (EYPT)

Is EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.

Keep Reading →

June 29th, 2019 - Hedge Funds News